FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study
A panel of advisers to the U.S. health regulator said on Tuesday Vertex Pharmaceuticals and CRISPR Therapeutics could
1970-01-01 08:00
Amgen gets US FTC's go-ahead for $27.8 billion Horizon deal
By Manas Mishra and David Shepardson (Reuters) -The U.S. Federal Trade Commission has allowed Amgen to go ahead with its
1970-01-01 08:00
US FTC suspends challenge to block Amgen's $27.8 billion deal for Horizon Therapeutics
The U.S. Federal Trade Commission (FTC) has suspended its challenge of Amgen's $27.8 billion purchase of Horizon Therapeutics,
1970-01-01 08:00
California, other states join FTC bid to block Amgen deal
The states of California, Minnesota and Wisconsin on Thursday joined a Federal Trade Commission lawsuit to stop Amgen's
1970-01-01 08:00
FTC effort to stop Amgen's Horizon takeover faces uphill fight
By Diane Bartz WASHINGTON The Federal Trade Commission (FTC) faces an uphill battle in its fight against Amgen
1970-01-01 08:00
US FTC sues to block Amgen's $27.8 billion deal for Horizon Therapeutics
By Diane Bartz and Leroy Leo WASHINGTON (Reuters) -The U.S. Federal Trade Commission said on Tuesday it has filed a
1970-01-01 08:00
FTC Commissioners yet to meet on Amgen-Horizon deal - CNBC
Commissioners at the U.S. Federal Trade Commission (FTC) have not yet met to discuss Amgen's acquisition of Horizon
1970-01-01 08:00
FTC to block Amgen's deal to acquire Horizon Therapeutics - source
The US Federal Trade Commission (FTC) is expected to file a lawsuit as early as Tuesday to block
1970-01-01 08:00